Skip to content
Search
Please enter at least 3 characters.

Latest Stories

Pharmacy technicians encouraged to advance their roles with fully funded CPPE programme

The roles of pharmacy technicians are being expanded to utilise their skills and knowledge more effectively
gettyimages

The roles of pharmacy technicians are being expanded to utilise their skills and knowledge more effectively

Community Pharmacy England (CPE) is encouraging pharmacy technicians working in community pharmacies to enhance their skills and broaden their roles by applying for the community pharmacy technician: advancing your role learning programme.

Interested individuals are informed that fully funded places are still available for this innovative learning initiative, offered by the Centre for Pharmacy Postgraduate Education (CPPE) and developed in collaboration with the Pharmacy Integration Programme at NHS England.


This programme is designed to develop the knowledge, clinical skills and behaviours of pharmacy technicians to increase patient access to clinical services by widening the skill mix in community pharmacy teams.

In a video, Liz Fidler, senior professional advisor pharmacy technician practice, explains the need for this programme by emphasising the evolving landscape of post-registration education opportunities for pharmacy technicians.

She says: “The roles of pharmacy technicians as regulated, autonomous healthcare professionals are being expanded to reflect utilising their skills and knowledge more effectively.

“The introduction of pharmacists joining the register in 2026 as independent prescribers means we have an opportunity to ensure that we are enabling all members of the pharmacy team to provide optimum services.”

Key policy enablers, such as the DHSC, proposed the addition of pharmacy technicians to the list of healthcare professionals able to supply and/or administer medicines or medicinal products via Patient Group Directions (PGDs).

She welcomes the inclusion of pharmacy technician post-registration roles in the delivery plan for recovering access to primary care, stating that it provides “a blueprint and role narrative recognising the contribution another registered profession in pharmacy can add.”

Fidler notes that this programme offers “an exciting opportunity” for the profession to utilise and build on their skills and knowledge, providing access to education, opportunities to contribute to delivering clinical services.

“Robust education that underpins building on pre-registration in initial education and training is critical to support the competent and confident in delivering services,” she adds.

Open to pharmacy technicians working in community pharmacy or the health and justice sector, the CPPE programme includes:

  • A self-directed e-course with six modules
  • A Learning Needs Analysis (LNA) and an initial meeting with an education supervisor to create an action plan
  • A face-to-face clinical assessment skills workshop
  • Practical workplace application of clinical assessment skills
  • A two-hour online workshop for reflective practice
  • Optional peer support sessions to build professional networks
  • Approximately 4-6 hours of learning per week

Interested community pharmacy technicians can apply here.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less